Understanding the evidence base and journey to HPV based self-collection for cervical cancer screening

Speaker:
Dr. Gina Ogilvie, MD, FCFP, DrPH, FRSC
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025